Barclays PLC Ideaya Biosciences, Inc. Transaction History

Barclays PLC

$357 Billion
Q4 2024

A detailed history of Barclays PLC transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Barclays PLC holds 198,756 shares of IDYA stock, worth $3.39 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

198,756

Previous 181,170 9.71%

Holding current value

$3.39 Million

Previous $5.74 Million 10.99%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$24.79 - $31.98 $435,956 - $562,400	17,586 Added 9.71%	198,756 $5.11 Million
Q3 2024 Nov 15, 2024	BUY	$30.37 - $43.05 $3.6 Million - $5.1 Million	118,438 Added 188.8%	181,170 $5.74 Million
Q2 2024 Aug 14, 2024	SELL	$34.37 - $43.46 $248,632 - $314,389	-7,234 Reduced 10.34%	62,732 $2.2 Million
Q1 2024 May 15, 2024	SELL	$34.2 - $47.13 $3.64 Million - $5.02 Million	-106,474 Reduced 60.35%	69,966 $3.07 Million
Q4 2023 Feb 15, 2024	BUY	$24.59 - $35.83 $2.22 Million - $3.23 Million	90,114 Added 104.39%	176,440 $6.28 Million
Q3 2023 Nov 07, 2023	BUY	$21.07 - $29.77 $274,942 - $388,468	13,049 Added 17.81%	86,326 $2.33 Million
Q2 2023 Aug 03, 2023	BUY	$13.33 - $25.53 $146,896 - $281,340	11,020 Added 17.7%	73,277 $1.72 Million
Q1 2023 May 04, 2023	SELL	$13.49 - $18.72 $432,840 - $600,649	-32,086 Reduced 34.01%	62,257 $855,000
Q4 2022 Feb 13, 2023	BUY	$14.47 - $18.17 $343,445 - $431,264	23,735 Added 33.62%	94,343 $1.72 Million
Q3 2022 Nov 03, 2022	BUY	$9.24 - $15.79 $630,574 - $1.08 Million	68,244 Added 2886.8%	70,608 $1.05 Million
Q2 2022 Aug 12, 2022	SELL	$8.28 - $13.88 $25,485 - $42,722	-3,078 Reduced 56.56%	2,364 $33,000
Q1 2022 May 16, 2022	SELL	$11.18 - $24.02 $383,675 - $824,318	-34,318 Reduced 86.31%	5,442 $61,000
Q4 2021 Feb 14, 2022	BUY	$20.95 - $26.88 $548,324 - $703,530	26,173 Added 192.63%	39,760 $940,000
Q3 2021 Nov 09, 2021	BUY	$17.26 - $27.08 $26,580 - $41,703	1,540 Added 12.78%	13,587 $347,000
Q2 2021 Aug 13, 2021	SELL	$17.76 - $24.83 $49,887 - $69,747	-2,809 Reduced 18.91%	12,047 $252,000
Q1 2021 May 13, 2021	BUY	$13.48 - $23.77 $129,623 - $228,572	9,616 Added 183.51%	14,856 $348,000
Q4 2020 Feb 11, 2021	SELL	$12.17 - $17.52 $24,778 - $35,670	-2,036 Reduced 27.98%	5,240 $73,000
Q3 2020 Nov 12, 2020	BUY	$11.22 - $14.46 $7,270 - $9,370	648 Added 9.78%	7,276 $91,000
Q2 2020 Aug 12, 2020	BUY	$3.59 - $18.57 $23,794 - $123,081	6,628 New	6,628 $94,000

Others Institutions Holding IDYA

# of Institutions

211

Shares Held

79.9M

Call Options Held

39.6K

Put Options Held

24.1K

View Full List

About IDEAYA Biosciences, Inc.

Ticker IDYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,067,700
Market Cap $820M
Description
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...

More about IDYA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account